Quick Answer
LEMAITRE VASCULAR INC reported Net Income Loss of $57.73 million for the year ending 2025.
- LEMAITRE VASCULAR INC showed an increase of +31.1% in Net Income Loss from 2024 to 2025.
- This data is from LEMAITRE VASCULAR INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $3.22 million | Q2 2017: $4.63 million | Q3 2017: $5.04 million | Q4 2017: $4.28 million | Q1 2018: $3.85 million | Q2 2018: $8.75 million | Q3 2018: $4.31 million | Q4 2018: $6.03 million | Q1 2019: $3.51 million | Q2 2019: $4.62 million | Q3 2019: $5.18 million | Q4 2019: $4.61 million | Q1 2020: $3.17 million | Q2 2020: $3.50 million | Q3 2020: $7.51 million | Q4 2020: $7.03 million | Q1 2021: $5.93 million | Q2 2021: $8.30 million | Q3 2021: $6.50 million | Q4 2021: $6.18 million | Q1 2022: $6.04 million | Q2 2022: $3.52 million | Q3 2022: $5.46 million | Q4 2022: $5.63 million | Q1 2023: $6.04 million | Q2 2023: $8.10 million | Q3 2023: $7.50 million | Q4 2023: $8.47 million | Q1 2024: $9.89 million | Q2 2024: $11.83 million | Q3 2024: $11.14 million | Q1 2025: $11.01 million | Q2 2025: $13.78 million | Q3 2025: $17.36 million.
- Over the full 17 years of available data (2009 to 2025), LEMAITRE VASCULAR INC's Net Income Loss has grown by 3,512.9%.
- Historical annual values: Fiscal year 2025: $57.73 million | Fiscal year 2024: $44.04 million | Fiscal year 2023: $30.11 million | Fiscal year 2022: $20.64 million | Fiscal year 2021: $26.91 million | Fiscal year 2020: $21.22 million | Fiscal year 2019: $17.93 million | Fiscal year 2018: $22.94 million | Fiscal year 2017: $17.18 million | Fiscal year 2016: $10.59 million | Fiscal year 2015: $7.76 million | Fiscal year 2014: $3.92 million | Fiscal year 2013: $3.20 million | Fiscal year 2012: $2.57 million | Fiscal year 2011: $2.14 million | Fiscal year 2010: $6.01 million | Fiscal year 2009: $1.60 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: